Leukocyte reduction in cardiovascular surgery

Perfusion

Volumn 16, Issue 5, 2001, Pages 371-380

  Morris, S J ^a  

^a Europa House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN PROTECTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CATTLE; CONTROLLED STUDY; DOG; HEART LUNG TRANSPLANTATION; HEART PROTECTION; HUMAN; LEUKAPHERESIS; LEUKOCYTE ACTIVATION; LEUKOPENIA; LUNG FUNCTION; LUNG TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0034830762     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600507     Document Type: Article

References (106)

1. Immune and inflammatory response after cardiopulmonary bypass
2. Neurological complications of cardiac surgery
3. Anti-inflammatory pre-treatment and the resultant effects of interleukin-10: Adjuncts to multi-therapeutical strategies
4. Protection of the pulmonary microvasculature by fine screen blood filtration
5. Filtration of shed mediastinal blood
6. Effects of leukocyte depletion of blood transfusions on postoperative complications
7. Prevention of lung injury during open heart operations for congenital heart defects
8. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass
9. Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery
10. The phloistic role of C3 leukotactic fragments in myocardial infarcts of rats
11. Complement and the damaging effects of cardiopulmonary bypass
12. Initiation of white cell activation during cardiopulmonary bypass: Cytokines and receptors
13. Twenty-four hour lung preservation by hypothermia and leukocyte depletion
14. The role of leukocyte depletion in reducing injury to the lung after hypothermic ischemia
15. Prevention of reperfusion injury in the neonatal heart with leukocyte depleted blood
16. Leukocyte depletion results in excellent heart-lung function after 12 h storage
17. Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion and liposomal superoxide dismutase
18. Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-flow phenomenon, and infarct size
19. Evidence for the role of neutrophils in reperfusion injury in cold cardioplegic ischemia in neonatal lambs
20. Successful twenty-four-hour lung preservation with donor core cooling and leucocyte depletion in an orthotopic double lung transplant model
21. Effects of terminal cardioplegia with leukocyte-depleted blood on heart grafts preserved for 24 h
22. Myocardial protective effect and its mechanism of leukocyte-depleted reperfusion in neonatal rabbit hearts
23. Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: A study in a chronic porcine model
24. The effects of a leukocyte-depleting filter on cerebral and renal recovery after deep hypothermic arrest
25. Leukocyte-depleted reperfusion after long cardioplegic arrest attenuates ischemia-reperfusion injury of the coronary endothelium and myocardium in rabbit hearts
26. Reduction of endothelial injury after hypothermic lung preservation by initial leukocyte-depleted reperfusion
27. The effect of leukocyte depletion on transplanted heart function and endothelial cell function. Poster abstract
28. Beneficial effects of leukocyte-depleted blood and low-potassium dextran solutions on microvascular permeability in preserved porcine lung
29. Effects of leukocyte-depleted warm blood cardioplegia on cardiac and endothelial function
30. Use of leukocyte depletion to decrease injury after lung preservation and rewarming: An experimental model
31. Prevention of the hypoxic reoxygenation injury with the use of a leukocyte-depleting filter
32. Leukocyte depletion of blood cardioplegia attenuates reperfusion injury
33. Leucocyte depletion in cardiothoracic surgery
34. Potential for reduction in morbidity and cost with total leucocyte control for cardiac surgery
35. Therapeutic applications of leukocyte filtration
36. The role of leucocytes in the systemic inflammatory response and the potential impact of leucocyte depletion
37. Clinical evaluation of the LeukoGuard (LG6) arterial line filter for routine open-heart surgery
38. Cost effectiveness of using a leucodepletion arterial line filter
39. Leucocyte depletion reduces postoperative oxygen requirements
40. Depletion of neutrophils by filtration during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status
41. The role of leucocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass
42. Does the duration of cardiopulmonary bypass influence the clinical effectiveness of leucocyte depleting arterial line filters?
43. The effect of leucocyte depletion during CPB on patients with a high preoperative alveolar oxygenation index
44. Use of leucocyte depleting arterial line filter during deep hypothermic cardiopulmonary bypass and circulatory arrest: Correlation with pulmonary function
45. Systemic leukocyte filtration during cardiopulmonary bypass
46. Evaluation of leukocyte-reducing arterial line filter (LG6) for post-operative lung function, using cardiopulmonary bypass
47. Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets
48. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery
49. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study
50. In-line leucocyte filtration during bypass. Clinical results from a randomised prospective trial
51. Leucocyte depleting vs non-leucocyte depleting filters. A prospective randomised study comparing oxygenation indices and time to extubation
52. Effects of a leucocyte depleting arterial line filter on perioperative proteolytic enzyme and free radical release in patients undergoing aortocoronary bypass surgery
53. Does activated neutrophil depletion on bypass by leuckocyte filtration reduce myocardial damage? A preliminary report
54. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury
55. The effect of leucocyte depletion on coronary sinus leucocyte count during cardiopulmonary bypass. Poster abstract
56. Brain damage during cardiopulmonary bypass
57. Leucocyte depleting arterial line filtration during CABG reduces microemboli but not S100
58. Heparin coating and leucofiltration during extracorporeal circulation reduces coagulation activation, blood loss and the need for substitution
59. Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements
60. Preservation of platelet reactivity with leucocyte reduction
61. Laboratory investigation of the Pall LG 6 leucocyte depleting arterial line filter
62. The effects of pulsatile flow on the leucocyte depleting qualities of the Pall LG6 leucocyte depleting arterial line filter: A laboratory investigation
63. Depletion of activated neutrophils by a filter during cardiac valve surgery
64. Laboratory studies on the effect of Pall extracorporeal filters LG6 and AV6 on patients undergoing coronary bypass grafts
65. A comparison of sequential total and activated white cell count in patients undergoing coronary artery bypass grafting, using cardiopulmonary bypass, with and without a white cell filter
66. Timing of leukocyte filtration during cardiopulmonary bypass
67. Increased rigidity and priming of polymorphonuclear leucocytes in sepsis
68. Are the occasional high pressure gradients associated with leucocyte-reducing filters and oxygenators a similar phenomenon?
69. Leukocyte depletion during cardiac operation: A new approach through the venous bypass circuit
70. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury
71. Leukocyte-depleted reperfusion of transplanted human hearts: A randomised, double blind clinical trial
72. The effects of using a leukocyte removal filter during cold blood cardioplegia
73. Myocardial protection with and without leucocyte depletion. A comparative study on the oxidative stress
74. Evaluation of leukocyte depleted terminal blood cardioplegia in patients undergoing elective and emergency coronary bypass grafting
75. Leucocyte filtered blood cardioplegia and controlled reperfusion
76. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy
77. Role of leukocytes in free radical production during myocardial revascularisation
78. Leukocyte filtration reduces myocardial reperfusion morbidity
79. Clinical evaluation of the new Pall leucocyte depleting blood cardioplegia filter (BC1)
80. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery
81. Experimental use of the blood cardioplegia filter BC1B
82. Single leukocyte filter (Pall BC1B) fails in multidose cold blood cardioplegia
83. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: A randomized, double-blind study
84. Leucocyte-depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery
85. Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation
86. Clinical evaluation of the Pall BC1B leukocyte depleting blood cardioplegia filter
87. Leukocyte-depleted continuous blood cardioplegia for coronary artery bypass grafting
88. Controlled reperfusion after lung ischemia: Implications for improved function after lung transplantation
89. Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation
90. Technique of controlled reperfusion of transplanted lung in humans
91. Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations
92. Autotransfusion after coronary artery bypass halves the number of patients needing blood transfusion
93. Cell salvage and leucodepletion
94. Autologous blood transfusion: Preoperative blood collection and blood salvage techniques
95. Leukocyte CD11b and CD18 expression are increased in blood salvaged for autotransfusion
96. The hidden hazards of blood transfusion during elective aortic aneurysm (AAA) repair - A comparison of autologous and homologous products
97. Pulmonary implications of filtering various mediators of morbidity found in salvaged blood
98. Risk neutralization in cardiac surgery with leukocyte reducing filters
99. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery
100. Does leukocyte filtration improve lung function in smokers after cardiopulmonary bypass (CPB)?
101. White cell depletion of residual blood after normothermic CPB
102. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass
103. Modifying risk for extracorporeal circulation: Trial of four anti-inflammatory strategies
104. Are leucocyte-depleting filters capable of selectively removing activated leucocytes during CPB?
105. Are leucocyte depleting filters still capable of removing activated leucocytes after non-specific absorbtion has ceased?